These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27733752)
1. Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database. Schiffmann J; Sun M; Gandaglia G; Tian Z; Popa I; Larcher A; Briganti A; McCORMACK M; Shariat SF; Montorsi F; Graefen M; Saad F; Karakiewicz PI Minerva Urol Nefrol; 2017 Apr; 69(2):173-180. PubMed ID: 27733752 [TBL] [Abstract][Full Text] [Related]
2. Contemporary 90-day mortality rates after radical cystectomy in the elderly. Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826 [TBL] [Abstract][Full Text] [Related]
3. Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study. Schiffmann J; Sun M; Gandaglia G; Tian Z; Popa I; Larcher A; Meskawi M; Briganti A; McCormack M; Shariat SF; Montorsi F; Graefen M; Saad F; Karakiewicz PI Can Urol Assoc J; 2016; 10(3-4):E82-6. PubMed ID: 27330584 [TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718 [TBL] [Abstract][Full Text] [Related]
6. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion. Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy Candidates. de Angelis M; Siech C; Jannello LMI; Bello FD; Peñaranda NR; Goyal JA; Touma N; Tian Z; Longo N; de Cobelli O; Chun FKH; Micali S; Saad F; Shariat SF; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI Clin Genitourin Cancer; 2024 Oct; 22(5):102132. PubMed ID: 38972785 [TBL] [Abstract][Full Text] [Related]
8. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341 [TBL] [Abstract][Full Text] [Related]
9. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530 [TBL] [Abstract][Full Text] [Related]
10. Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. Sammon JD; Morgan M; Djahangirian O; Trinh QD; Sun M; Ghani KR; Jeong W; Jhaveri J; Ehlert M; Schmitges J; Bianchi M; Shariat SF; Perrotte P; Rogers CG; Peabody JO; Menon M; Karakiewicz PI BJU Int; 2012 Nov; 110(9):1301-9. PubMed ID: 22449122 [TBL] [Abstract][Full Text] [Related]
11. National comparison of oncologic quality indicators between open and robotic-assisted radical cystectomy. Matulewicz RS; DeLancey JO; Manjunath A; Tse J; Kundu SD; Meeks JJ Urol Oncol; 2016 Oct; 34(10):431.e9-431.e15. PubMed ID: 27264169 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155 [TBL] [Abstract][Full Text] [Related]
13. Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. Zargar-Shoshtari K; Kongnyuy M; Sharma P; Fishman MN; Gilbert SM; Poch MA; Pow-Sang JM; Spiess PE; Zhang J; Sexton WJ World J Urol; 2016 Nov; 34(11):1567-1573. PubMed ID: 27072536 [TBL] [Abstract][Full Text] [Related]
14. Use of radical cystectomy for patients with invasive bladder cancer. Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS; J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716 [TBL] [Abstract][Full Text] [Related]
15. Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder. Kosiba M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI Clin Genitourin Cancer; 2022 Apr; 20(2):195.e1-195.e8. PubMed ID: 34906434 [TBL] [Abstract][Full Text] [Related]
16. A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy. Soave A; Riethdorf S; Dahlem R; von Amsberg G; Minner S; Weisbach L; Engel O; Fisch M; Pantel K; Rink M Int J Cancer; 2017 Jan; 140(2):381-389. PubMed ID: 27668704 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer. Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study. Dell'Oglio P; Abou-Haidar H; Leyh-Bannurah SR; Tian Z; Larcher A; Gandaglia G; Fossati N; Shariat SF; Capitanio U; Briganti A; Montorsi F; Graefen M; Saad F; Karakiewicz PI Eur Urol; 2016 Sep; 70(3):429-35. PubMed ID: 26951945 [TBL] [Abstract][Full Text] [Related]
19. Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database. Darwish C; Sparks A; Amdur R; Reddy A; Whalen M Urology; 2020 Dec; 146():168-176. PubMed ID: 32866509 [TBL] [Abstract][Full Text] [Related]
20. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study. Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]